CS-101 is Shanghai-based CorrectSequence's lead candidate, which it is developing for treating sickle-cell disease and ...
CS-101 is Shanghai-based CorrectSequence's lead candidate, which it is developing for treating sickle-cell disease and ...
Beam Therapeutics Inc. pivots from platform story to execution-driven thesis, with regulatory clarity accelerating BEAM-302 ...
The "In Situ Hybridization Market Report by Product, Technique, Application, End User, Countries and Company Analysis ...
Non-coding DNA is essential for both humans and trypanosomes, despite the large evolutionary divergence between these two species.
In their recent Review article, Barzel and Kupiec 1 analyse some important issues concerning how homologous DNA sequences pair to facilitate homologous recombination (HR). However, the models ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback